Editorial: real‐life data confirm efficacy of elbasvir/grazoprevir in <scp>HCV</scp> patients with severe kidney disease
Maria Grazia Rumi(University of Milan), Vincenzo Occhipinti(University of Milan)
Cited by 2
Related Papers
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|405
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394